Clinical Trial: A Study to Evaluate the Performance and Safety of Artelac(R) Complete MDO(R) Versus VISMED(R) MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07593885) titled 'A Study to Evaluate the Performance and Safety of Artelac(R) Complete MDO(R) Versus VISMED(R) MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease' on May 12.

Brief Summary: A Double-Masked, Randomized, Parallel Group, Non-Inferiority Study to Evaluate the Performance and Safety of Artelac(R) Complete MDO(R) Versus VISMED(R) MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Dry Eye

Intervention: DRUG: Artelac(R) Complete MDO(R) Eye Drops

Self-administered eye drops

DRUG: VISMED(R) MULTI Eye Drops

Self-administered eye dr...